The reemergence of long-term potentiation in aged Alzheimer’s disease mouse model
Open Access
- 5 July 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 29152
Abstract
Mouse models of Alzheimer’s disease (AD) have been developed to study the pathophysiology of amyloid β protein (Aβ) toxicity, which is thought to cause severe clinical symptoms such as memory impairment in AD patients. However, inconsistencies exist between studies using these animal models, specifically in terms of the effects on synaptic plasticity, a major cellular model of learning and memory. Whereas some studies find impairments in plasticity in these models, others do not. We show that long-term potentiation (LTP), in the CA1 region of hippocampal slices from this mouse, is impared at Tg2576 adult 6–7 months old. However, LTP is inducible again in slices taken from Tg2576 aged 14–19 months old. In the aged Tg2576, we found that the percentage of parvalbumin (PV)-expressing interneurons in hippocampal CA1-3 region is significantly decreased, and LTP inhibition or reversal mediated by NRG1/ErbB signaling, which requires ErbB4 receptors in PV interneurons, is impaired. Inhibition of ErbB receptor kinase in adult Tg2576 restores LTP but impairs depotentiation as shown in aged Tg2576. Our study suggests that hippocampal LTP reemerges in aged Tg2576. However, this reemerged LTP is an insuppressible form due to impaired NRG1/ErbB signaling, possibly through the loss of PV interneurons.Keywords
This publication has 61 references indexed in Scilit:
- The Importance of the NRG-1/ErbB4 Pathway for Synaptic Plasticity and Behaviors Associated with Psychiatric DisordersJournal of Neuroscience, 2012
- Motor impulsivity in APP-SWE mice: a model of Alzheimer??s diseaseBehavioural Pharmacology, 2006
- Neuregulin‐1 polymorphism in late onset Alzheimer's disease families with psychosesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivoNature Medicine, 2005
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2001
- Diversity and Dynamics of Dendritic SignalingScience, 2000
- Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP miceBrain Research, 1999
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Factors regulating the reversibility of long-term potentiationJournal of Neuroscience, 1996